Preoperative β‐lactam antibiotic prophylaxis is superior to bacteriostatic alternatives in immediate expander‐based breast reconstruction

Abstract

Staged implant‐based breast reconstruction is the most common reconstructive modality following mastectomy. Postoperative implant infections can have a significant impact on adjuvant oncologic care and reconstructive outcome. Here, we investigate the impact of β‐lactam antibiotics (i.e., bactericidal) compared to alternative antibiotic agents on postoperative outcomes for implant‐based breast reconstruction.